BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31759986)

  • 21. A novel subtype classification and risk of breast cancer by histone modification profiling.
    Chen X; Hu H; He L; Yu X; Liu X; Zhong R; Shu M
    Breast Cancer Res Treat; 2016 Jun; 157(2):267-279. PubMed ID: 27178334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feature selection and classification of MAQC-II breast cancer and multiple myeloma microarray gene expression data.
    Liu Q; Sung AH; Chen Z; Liu J; Huang X; Deng Y
    PLoS One; 2009 Dec; 4(12):e8250. PubMed ID: 20011240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accurate molecular classification of cancer using simple rules.
    Wang X; Gotoh O
    BMC Med Genomics; 2009 Oct; 2():64. PubMed ID: 19874631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
    Aka JA; Calvo EL; Lin SX
    Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive sensitivity analysis of microarray breast cancer classification under feature variability.
    Sontrop HM; Moerland PD; van den Ham R; Reinders MJ; Verhaegh WF
    BMC Bioinformatics; 2009 Nov; 10():389. PubMed ID: 19941644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomics-based screening of molecular signatures associated with patients overall survival and their key regulators in subtypes of breast cancer.
    Eskandari E; Motalebzadeh J
    Cancer Genet; 2019 Nov; 239():62-74. PubMed ID: 31569063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer.
    Xu M; Kao MC; Nunez-Iglesias J; Nevins JR; West M; Zhou XJ
    BMC Genomics; 2008; 9 Suppl 1(Suppl 1):S12. PubMed ID: 18366601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tree-based analysis of microarray data for classifying breast cancer.
    Zhang H; Yu CY
    Front Biosci; 2002 May; 7():c63-7. PubMed ID: 11991861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust edge-based biomarker discovery improves prediction of breast cancer metastasis.
    Adnan N; Lei C; Ruan J
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):359. PubMed ID: 32998692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using a single neuron as a marker selector: a breast cancer case study.
    Blazadonakis ME; Perperoglou A; Zervakis M
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():4219-22. PubMed ID: 18002933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated Identification of Core Regulatory Genes in Human Gene Regulatory Networks.
    Narang V; Ramli MA; Singhal A; Kumar P; de Libero G; Poidinger M; Monterola C
    PLoS Comput Biol; 2015; 11(9):e1004504. PubMed ID: 26393364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
    Tormo E; Pineda B; Serna E; Guijarro A; Ribas G; Fores J; Chirivella E; Climent J; Lluch A; Eroles P
    J Cell Biochem; 2015 Sep; 116(9):2061-73. PubMed ID: 25802200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multiple kernel support vector machine scheme for feature selection and rule extraction from gene expression data of cancer tissue.
    Chen Z; Li J; Wei L
    Artif Intell Med; 2007 Oct; 41(2):161-75. PubMed ID: 17851055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of gene importance in microarray data based upon probability of selection.
    Fu LM; Fu-Liu CS
    BMC Bioinformatics; 2005 Mar; 6():67. PubMed ID: 15784140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
    Guo L; Zhang K; Bing Z
    Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of diagnosis system and gene regulatory networks based on microarray analysis.
    Hong CF; Chen YC; Chen WC; Tu KC; Tsai MH; Chan YK; Yu SS
    J Biomed Inform; 2018 May; 81():61-73. PubMed ID: 29550394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Efficient Mixed-Model for Screening Differentially Expressed Genes of Breast Cancer Based on LR-RF.
    Sun M; Ding T; Tang XQ; Keming Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):124-130. PubMed ID: 29993693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a transcriptional signature of breast cancer.
    Feng Y; Li X; Sun B; Wang Y; Zhang L; Pan X; Chen X; Wang X; Wang J; Hao X
    Breast Cancer Res Treat; 2010 Jul; 122(1):65-75. PubMed ID: 19728083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A probabilistic approach for automated discovery of perturbed genes using expression data from microarray or RNA-Seq.
    Sundaramurthy G; Eghbalnia HR
    Comput Biol Med; 2015 Dec; 67():29-40. PubMed ID: 26492320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer classification from time series microarray data through regulatory Dynamic Bayesian Networks.
    Kourou K; Rigas G; Papaloukas C; Mitsis M; Fotiadis DI
    Comput Biol Med; 2020 Jan; 116():103577. PubMed ID: 32001012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.